ethyl methanesulfonate has been researched along with Abnormalities, Drug-Induced in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gocke, E; Müller, L; Pfister, T | 1 |
Bürgin, H; Gocke, E; Müller, L; Pfister, T | 1 |
Faustman, EM; Seeley, MR | 1 |
Bochert, G; Meister, R; Neubert, D; Platzek, T | 1 |
Bochert, G; Platzek, T | 1 |
Bergstrom, RA; Browning, VL; John, SW; Libby, B; Munroe, RJ; Schimenti, JC; Schimenti, KJ; Smith, R; Zheng, QY | 1 |
Cacheiro, NL; Cain, KT; Cornett, CV; Generoso, WM; Katoh, M; Rutledge, JC | 1 |
Cain, KT; Downing, DJ; Generoso, WM; Hughes, LA; Rutledge, JC | 1 |
Lyon, MF; Renshaw, R | 1 |
2 review(s) available for ethyl methanesulfonate and Abnormalities, Drug-Induced
Article | Year |
---|---|
Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents, Alkylating; DNA; DNA Damage; Dose-Response Relationship, Drug; Drug Contamination; Ethyl Methanesulfonate; Female; HIV Protease Inhibitors; Humans; Male; Mice; Nelfinavir; Neoplasms; No-Observed-Adverse-Effect Level; Rats; Reproduction; Risk Assessment; Toxicity Tests | 2009 |
Embryotoxicity induced by alkylating agents: 7. Low dose prenatal-toxic risk estimation based on NOAEL risk factor approach, dose-response relationships, and DNA adducts using methylnitrosourea as a model compound.
Topics: Abnormalities, Drug-Induced; Algorithms; Alkylating Agents; Alkylation; Animals; DNA; DNA Damage; Dose-Response Relationship, Drug; Embryo, Mammalian; Ethyl Methanesulfonate; Female; Fetal Death; Guanine; Methylnitrosourea; Mice; Models, Theoretical; Pregnancy; Risk Factors; Toxicology | 1993 |
7 other study(ies) available for ethyl methanesulfonate and Abnormalities, Drug-Induced
Article | Year |
---|---|
EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations.
Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents, Alkylating; Carcinogenicity Tests; Dose-Response Relationship, Drug; Drug Contamination; Ethyl Methanesulfonate; Female; Genes, Dominant; Genes, Lethal; Germ-Line Mutation; HIV Protease Inhibitors; Humans; Linear Models; Mammary Neoplasms, Animal; Methyl Methanesulfonate; Mice; Mutagenicity Tests; Nelfinavir; No-Observed-Adverse-Effect Level; Pregnancy; Quantitative Structure-Activity Relationship; Rats; Risk Assessment | 2009 |
Toxicity of four alkylating agents on in vitro rat embryo differentiation and development.
Topics: Abnormalities, Drug-Induced; Animals; Cell Differentiation; Cells, Cultured; Central Nervous System; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Ethyl Methanesulfonate; Ethylnitrosourea; Female; Forelimb; Methyl Methanesulfonate; Methylnitrosourea; Rats | 1995 |
Embryotoxicity induced by alkylating agents: 10. Analysis of the combined teratogenic effects of methylnitrosourea and ethylmethanesulfonate in mice.
Topics: Abnormalities, Drug-Induced; Alkylating Agents; Animals; Bone and Bones; Dose-Response Relationship, Drug; Drug Synergism; Ethyl Methanesulfonate; Female; Methylnitrosourea; Mice; Pregnancy | 1995 |
Mouse mutants from chemically mutagenized embryonic stem cells.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Bone and Bones; Chimera; Ethyl Methanesulfonate; Ethylnitrosourea; Female; Genes, Lethal; Hypoxanthine Phosphoribosyltransferase; Limb Deformities, Congenital; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutagenesis; Mutagens; Point Mutation; Retina; RNA Splicing; Stem Cells; Testis | 2000 |
Fetal anomalies produced subsequent to treatment of zygotes with ethylene oxide or ethyl methanesulfonate are not likely due to the usual genetic causes.
Topics: Abnormalities, Drug-Induced; Animals; Cleavage Stage, Ovum; Cytogenetics; Embryo Transfer; Ethyl Methanesulfonate; Ethylene Oxide; Female; Fetal Death; Mice; Pregnancy; Zygote | 1989 |
Mutagen-induced fetal anomalies and death following treatment of females within hours after mating.
Topics: Abnormalities, Drug-Induced; Animals; Cleavage Stage, Ovum; Embryo Implantation; Ethyl Methanesulfonate; Ethylene Oxide; Ethylnitrosourea; Female; Fetal Death; Mice; Mutagens; Oocytes; Ovum; Pregnancy; Triethylenemelamine; Zygote | 1988 |
Induction of congenital malformations in the offspring of mutagen treated mice.
Topics: Abnormalities, Drug-Induced; Abnormalities, Radiation-Induced; Animals; Ethyl Methanesulfonate; Ethylnitrosourea; Female; Mice; Mice, Inbred C3H; Mutagens; Pregnancy; Prenatal Exposure Delayed Effects | 1986 |